Cargando…
Evaluating New Compounds to Treat Burkholderia pseudomallei Infections
Burkholderia pseudomallei is the causative agent of melioidosis, a disease that requires long-term treatment regimens with no assurance of bacterial clearance. Clinical isolates are intrinsically resistant to most antibiotics and in recent years, isolates have been collected that display resistance...
Autores principales: | Ross, Brittany N., Myers, Julia N., Muruato, Laura A., Tapia, Daniel, Torres, Alfredo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036294/ https://www.ncbi.nlm.nih.gov/pubmed/30013953 http://dx.doi.org/10.3389/fcimb.2018.00210 |
Ejemplares similares
-
Burkholderia pseudomallei BimC Is Required for Actin-Based Motility, Intracellular Survival, and Virulence
por: Srinon, Varintip, et al.
Publicado: (2019) -
Genome-wide transposon mutagenesis analysis of Burkholderia pseudomallei reveals essential genes for in vitro and in vivo survival
por: Wong, Yee-Chin, et al.
Publicado: (2022) -
Serum From Melioidosis Survivors Diminished Intracellular Burkholderia pseudomallei Growth in Macrophages: A Brief Research Report
por: Chaichana, Panjaporn, et al.
Publicado: (2020) -
Osteomyelitis and Septic Arthritis Due to Burkholderia pseudomallei: A 10-Year Retrospective Melioidosis Study From South China
por: Wu, Hua, et al.
Publicado: (2021) -
Preliminary Evaluation of Rapid Visual Identification of Burkholderia pseudomallei Using a Newly Developed Lateral Flow Strip-Based Recombinase Polymerase Amplification (LF-RPA) System
por: Li, Jin, et al.
Publicado: (2022)